Suing Over a Nobel

The scientist who sued the Nobel committee is now suing Nobel winner Shinya Yamanaka.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JONATHUNDEREarlier this year California surgeon Rongxiang Xu sued the Nobel Committee for failing to recognize him in 2012 for his work on regenerative medicine. Yesterday (May 15) he announced that he is also suing one of the prize’s winners, Shinya Yamanaka, who was honored for his work on stem cells along with fellow scientist John Gurdon.

Xu, founder of the regenerative medicine company MEBO, claimed in his suit that Yamanaka is guilty of slander of title, defamation, trade libel, unfair competition, and negligent interference with prospective economic advantage. A press release said that Xu had patented the ability to turn differentiated somatic cells into stem cells before Yamanaka stated that he had done the same, detracting from Xu’s reputation. Moreover the release said that Yamanaka did not really “obtain natural pluripotent stem cells by somatic cell induction,” calling his stem cell work a “ridiculous scientific scam.”

Xu has not published any of his purported work on stem cells in peer-reviewed journals listed in PubMed. When asked a few months ago about Xu’s research, stem cell scientists were skeptical. “Dr. Xu says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Kate Yandell

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo